Back
Akero Therapeutics Stock Price Chart
Sponsored
AKRO
Sponsored
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
67
AKRO
Akero Therapeutics
Last Price:
31.14
Seasonality Move:
5.92%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.- The current trend is moderately bearish and AKRO is experiencing slight selling pressure.
Akero Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 30.77 | Buy |
20-day SMA: | 31.78 | Sell |
50-day SMA: | 30.06 | Buy |
200-day SMA: | 25.47 | Buy |
8-day EMA: | 31.34 | Sell |
20-day EMA: | 31.21 | Sell |
50-day EMA: | 30.06 | Buy |
200-day EMA: | 27.38 | Buy |
Akero Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.3 | Buy |
Relative Strength Index (14 RSI): | 50.59 | Buy |
Chaikin Money Flow: | -118449 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (29.5 - 33.2) | Sell |
Bollinger Bands (100): | (25.34 - 30.7) | Buy |
Akero Therapeutics Technical Analysis
Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Akero Therapeutics Stock
Is Akero Therapeutics Stock a Buy?
- Akero Therapeutics share price is 31.16 while AKRO 8-day simple moving average is 30.77, which is a Buy signal.
- The stock price of AKRO is 31.16 while Akero Therapeutics 20-day SMA is 31.78, which makes it a Sell.
- Akero Therapeutics 50-day simple moving average is 30.06 while AKRO share price is 31.16, making it a Buy technically.
- AKRO stock price is 31.16 and Akero Therapeutics 200-day simple moving average is 25.47, creating a Buy signal.
AKRO Technical Analysis vs Fundamental Analysis
Buy
67
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy or a Sell?
-
Akero Therapeutics stock is rated a Buy
The current Akero Therapeutics [AKRO] share price is $31.16. The Score for AKRO is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
Akero Therapeutics Stock Info
Market Cap:
2.17B
Price in USD:
31.16
Share Volume:
396.81K
Akero Therapeutics 52-Week Range
52-Week High:
37.00
52-Week Low:
15.32
Buy
67
Akero Therapeutics (AKRO)
is a Buy
Akero Therapeutics Share Price Forecast
-
What is the Akero Therapeutics stock price today?
The Akero Therapeutics stock price is 31.16 USD today. -
Will AKRO stock go up or go down?
Akero Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Akero Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Akero Therapeutics is not overvalued.
Is Akero Therapeutics Stock a Buy?
- Akero Therapeutics share price is 31.16 while AKRO 8-day exponential moving average is 31.34, which is a Sell signal.
- The stock price of AKRO is 31.16 while Akero Therapeutics 20-day EMA is 31.21, which makes it a Sell.
- Akero Therapeutics 50-day exponential moving average is 30.06 while AKRO share price is 31.16, making it a Buy technically.
- AKRO stock price is 31.16 and Akero Therapeutics 200-day simple moving average is 27.38, creating a Buy signal.
Fundamental Analysis of Akero Therapeutics
Is Akero Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.08 per share, and a decrease next year of $0.90 per share.
Technical Analysis of Akero Therapeutics
Should I short Akero Therapeutics stock?
- AKRO Moving Average Covergence Divergence (MACD) indicator is 0.3, suggesting Akero Therapeutics is a Buy
- Akero Therapeutics Relative Strength Index (RSI) is 50.59, which suggest Akero Therapeutics is overbought
- The Bollinger Bands (25) for Akero Therapeutics is (29.5 - 33.2), which suggest Akero Therapeutics is a Buy
- The Bollinger Bands (100) for Akero Therapeutics is (25.34 - 30.7), which suggest Akero Therapeutics is a Buy
* Akero Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.